摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-isonicotinoylbenzenesulfonohydrazide | 16827-12-6

中文名称
——
中文别名
——
英文名称
N'-isonicotinoylbenzenesulfonohydrazide
英文别名
N-benzenesulfonyl-N'-isonicotinoyl hydrazine;N-Benzolsulfonyl-N'-isonicotinoyl-hydrazin;N'-(benzenesulfonyl)pyridine-4-carbohydrazide
N'-isonicotinoylbenzenesulfonohydrazide化学式
CAS
16827-12-6
化学式
C12H11N3O3S
mdl
——
分子量
277.304
InChiKey
UKJCMAQTXOTHNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    96.5
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    N'-isonicotinoylbenzenesulfonohydrazide双氧水溶剂黄146 作用下, 生成 N-benzenesulfonyl-N'-(1-oxy-isonicotinoyl)-hydrazine
    参考文献:
    名称:
    31. N-氧化物和相关化合物。第七部分 一些共轭吡啶的过酸氧化
    摘要:
    DOI:
    10.1039/jr9580000150
  • 作为产物:
    描述:
    苯磺酰氯 在 sodium carbonate 作用下, 以79.4%的产率得到N'-isonicotinoylbenzenesulfonohydrazide
    参考文献:
    名称:
    Benzenesulfonohydrazides inhibiting urease: Design, synthesis, their in vitro and in silico studies
    摘要:
    Keeping in view the therapeutic importance of ureases due to its involvement in different pathological conditions, its inhibition was investigated by newly synthesized benzenesulfonohydrazides. Elemental analysis, IR, H-1 NMR and C-13 NMR spectral studies were performed to elucidate the structure of benzenesulfonohydrazides. In vitro urease enzyme inhibition assay revealed the compound INS-5 was found to be the most potent (IC50 = 1.11 +/- 0.29 mu M) among the tested compounds. The compound INS-2 was competitive inhibitor with Ki value 5.60 mu M while the compounds INS-1 and INS-5 were mixed type of inhibitors with Ki values 4.32 and 2.76 mu M respectively. Ancillary to synthetic studies, DFT and TDDFT calculations at B3LYP/6-311G(d,p) level of theory were performed for comparative analysis of spectroscopic data, frontier molecular orbitals (FMOs), natural bond orbital (NBO) analysis and molecule electrostatic potential (MEP) surface. Overall, experimental findings were supported nicely by corresponding DFT computed results. The NBO analysis confirmed that the presence of hyperconjugative interactions are pivotal cause for stability of investigated compounds. Global reactivity descriptors were also calculated using the energies of FMOs energies. Molecular docking studies were performed to identify the plausible binding mode of the competitive inhibitor. (C) 2020 Published by Elsevier B.V.
    DOI:
    10.1016/j.molstruc.2020.128740
点击查看最新优质反应信息

文献信息

  • Cucurbituril-resisted acylation of the anti-tuberculosis drug isoniazidvia a supramolecular strategy
    作者:Hang Cong、Chun-Rong Li、Sai-Feng Xue、Zhu Tao、Qian-Jiang Zhu、Gang Wei
    DOI:10.1039/c0ob00114g
    日期:——
    A chemical investigation reveals that the resistance to acylation of an anti-tuberculosis drug, isoniazid is a consequent result of the inclusion or exclusion of cucurbit[n]urils (n = 6 or 7). The 1H NMR spectra analysis shows that the different interaction models of the isoniazid with the two cucurbiturils are dependent on the cavity size of the hosts. Quantum chemistry calculations with density functional theory method indicate that the interaction of the isoniazid with both cucurbiturils is through thermodynamic stabilization in both the gas phase and aqueous solution through hydrogen bonding on the portal carbonyls of the cucurbiturils. Electronic absorption titration spectra suggest the hosts and guest interact in a ratio of 1 : 1 with moderate binding constants. Acylation kinetics of isoniazid with various acylating agents in the presence of the cucurbiturils revealed that resistance is only dependent on the host–isoniazid ratio, and independent on the size of the cucurbiturils and the species of acylating agents.
    一项化学调查显示,抗结核药物异烟肼的酰化抗性是包含或排除葫芦[n]脲(n = 6 或 7)的结果。1H NMR 光谱分析显示,异烟肼与两种葫芦脲的不同相互作用模型取决于宿主的空腔大小。用密度泛函理论方法进行的量子化学计算表明,异烟肼与两种葫芦素的相互作用是通过葫芦素的门户羰基上的氢键在气相和水溶液中实现热力学稳定的。电子吸收滴定光谱表明,宿主和客体的相互作用比例为 1 :1 的比例相互作用,结合常数适中。异烟肼与各种酰化剂在葫芦素存在下的酰化动力学表明,抗性只取决于宿主与异烟肼的比例,而与葫芦素的大小和酰化剂的种类无关。
  • Fujikawa et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1959, vol. 79, p. 1231,1233
    作者:Fujikawa et al.
    DOI:——
    日期:——
  • SYNTHETIC TUBERCULOSTATS. II. AMINO- AND HYDROXY-PYRIDINE CARBOXYLIC ACID DERIVATIVES
    作者:H. HERBERT FOX
    DOI:10.1021/jo01138a006
    日期:1952.4
  • The Synthesis of the Three Isomeric dl-β-Pyridylalanines
    作者:Carl Niemann、Richard N. Lewis、John T. Hays
    DOI:10.1021/ja01259a059
    日期:1942.7
  • Pyridine compounds and method of manufacture
    申请人:HOFFMANN LA ROCHE
    公开号:US02676178A1
    公开(公告)日:1954-04-20
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐